AI assistant
Solana Co — Director's Dealing 2020
Feb 4, 2020
32724_dirs_2020-02-04_74ef085b-b3be-4d9e-b3a5-d5fa71f8a656.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2020-01-31
Reporting Person: Deschamps Philippe (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-31 | Class A Common Stock | A | 3959 | $1.01 | Acquired | 37007 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 666911 | Indirect |
Footnotes
F1: These shares are represented by fully vested restricted stock awards (the "RSAs").
F2: The RSAs were issued to the Reporting Person in connection with the Reporting Person's election to participate in the Company's salary reduction program, pursuant to which the Reporting Person will receive RSAs in lieu of a percentage of the Reporting Person's cash compensation.
F3: These securities are directly held by Deschamps Global Healthcare Commercialization LLC (the "LLC") and includes shares previously held directly by MPJ Healthcare, LLC ("MPJ"). The Reporting Person is a member of MPJ and is the sole member of the LLC.